Your Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
DeCODE Reinstated to Nasdaq Global Market
deCODE genetics, 06/29/09
DeCODE genetics announced that it has received notice from the the Nasdaq Hearing and Listing Review Council that the listing of the company's common stock will be reinstated to the Nasdaq Global Market effective from the opening of trading on Monday, June. deCODE's common stock will continue to trade under the symbol DCGN.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Personalized Medicine Market To Grow 11% Annually
PharmExec, 12/16/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09
Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
Alcon, 12/15/09

See Latest Articles